P080 Comparison of efficacy of innovator molecule of itraconazole with generic forms of itraconazole in treatment naïve subjects with chronic pulmonary aspergillosis

POSTER SESSION 1, SEPTEMBER 21, 2022, 12:30 PM - 1:30 PM:   OBJECTIVE: Itraconazole capsule has a variable and unpredictable bioavailability. Whether generic brands of itraconazole are as effective as the innovator molecule in the treatment of subjects with chronic pulmonary aspergillosis (CPA) is u...

Descripción completa

Detalles Bibliográficos
Autores principales: Sehgal, Inderpaul, Vinay, Keshavamurth, Agarwal, Ritesh, Rudramurth, Shivaprakash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Oral Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509747/
http://dx.doi.org/10.1093/mmy/myac072.P080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509747/
http://dx.doi.org/10.1093/mmy/myac072.P080

Ejemplares similares